tm logo
LONG BRIDGE MEDICAL
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 03 Sep 2024

Last Applicant/ Owned by

6000 Shoreline Court, Suite 206

South San Francisco

CA

94080

Serial Number

98102684 filed on 26th Jul 2023

Registration Number

N/A

Correspondent Address

Andrew Ehard

Andrew Ehard MERCHANT & GOULD P.C.

MINNEAPOLIS, MN 55402-0910

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LONG BRIDGE MEDICAL

Medical device for the eye that stabilizes and holds in position an intraocular lens. pharmaceutical preparations for treating chronic drug elutions to the eye sold pre-filled in medical devices for the eye that stablilizes and holds in position an intraocular lense

Classification Information


Class [010]
Medical Instrument Products


Medical device for the eye that stabilizes and holds in position an intraocular lens.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


pharmaceutical preparations for treating chronic drug elutions to the eye sold pre-filled in medical devices for the eye that stablilizes and holds in position an intraocular lense


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98102684

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 18695.03US01

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

07.11.01 -

Bridges

Legal History


Show more

Status DateAction Taken
03rd Sep 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09th Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09th Jul 2024PUBLISHED FOR OPPOSITION
19th Jun 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04th Jun 2024EXAMINERS AMENDMENT -WRITTEN
04th Jun 2024EXAMINER'S AMENDMENT ENTERED
04th Jun 2024EXAMINERS AMENDMENT E-MAILED
04th Jun 2024APPROVED FOR PUB - PRINCIPAL REGISTER
04th Jun 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03rd Jun 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED